ArchiMed Hires Two Health-Care Executives as Partners
By ED BALLARD, Feb. 12, 2018
ArchiMed Group, a France-based private-equity firm that specializes in health-care investments, has appointed two industry executives as partners.
The two new arrivals, Benoît Adelus and André-Michel Ballester, bring the number of partners at the firm to eight, Archimed said in a press release.
Both men have over 30 years’ experience in the health-care industry and were previously part of ArchiMed’s network of industry advisers.
Mr. Adelus spent the past decade as chairman and chief executive of medical diagnostics company Sebia SA.
Sebia changed hands five times during his tenure. Most recently it was sold last year by Astorg Partners and Montagu Private Equity to CVC Capital Partners, Téthys Invest and Caisse de Dépôt et Placement du Québec.
Mr. Adelus stepped down as chief executive in September but remains Sebia’s chairman.
Mr. Ballester is currently chairman of Citieffe, a Swiss orthopedic device manufacturer acquired by ArchiMed in 2014.
He previously spent eight years as chief executive of cardiac device maker Sorin Biomedica, overseeing more 18 mergers and acquisitions.
ArchiMed closed its second fund at its €315 million hard cap in September after a four-month fundraising campaign.
The Lyon, France-based firm was formed in 2014 by former sector specialists at U.K. buyout firm 3i Group PLC. It targets lower midmarket private-equity firms in the health-care space, investing between €5 million and €50 million ($6.1 million-$61.4 million) per deal.
Write to Ed Ballard at email@example.com
Source: WSJ Pro a Dow Jones Company